A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Rethinking Trust in Synthetic Health Data: Lessons From 7 European Research Initiatives




TekijätDeclerck, Jens; Kalra, Dipak; Airola, Antti; Amer, Ahmed Youssef Ali; Chatzichristos, Christos; del Mar Mañu Pereira, Maria; de Brito Robalo, Bruno M.; Ghini, Francesco; Gutierrez-Torre, Alberto; Hoogteijling, Sem; Hultsch, Susanne; Ramon, Jan; Reidel, Sara; Regazzoni, Francesco; Silva, Luís; Silveira, Inês; Sofia, Tsekeridou; Maes, Christophe

KustantajaJMIR Publications Inc.

Julkaisuvuosi2026

Lehti: Journal of Medical Internet Research

Artikkelin numeroe83369

Vuosikerta28

ISSN1439-4456

eISSN1438-8871

DOIhttps://doi.org/10.2196/83369

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Kokonaan avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.2196/83369

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/523444888

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä

Synthetic data generation (SDG) structured health data is increasingly promoted as a solution to longstanding barriers in health data access. It is offering the promise of privacy-preserving data reuse for research, innovation, and policy. Despite rapid technical advances, the adoption of synthetic health data in real-world settings remains limited. Shaped by challenges around data quality, representativeness, infrastructure readiness, trust, and legal uncertainty, this viewpoint draws on experiences from 7 European research initiatives within the HealthData4EU cluster to reflect on how SDG is being operationalized in practice. It synthesizes cross-project insights to highlight recurring methodological and governance tensions and to examine their implications for trust and responsible use. The analysis argues that trustworthy SDG cannot be achieved through technical optimization alone but requires alignment between evaluation practices, upstream data stewardship, regulatory clarity, and sustained stakeholder engagement. Addressing these conditions is essential for moving synthetic data from experimental pilots toward a credible and sustainable component of European health research ecosystems.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This paper was funded by the Innovative Health Initiative through the SYNTHIA project. The study draws on insights from 7 research projects that form part of the HealthData4EU cluster. Projects within the cluster and their funding sources are as follows. SYNTHEMA, PHASE IV AI, SECURED, FLUTE, and AISym4MED are funded by the Horizon Europe program. PHEMS is funded by Horizon Europe and UK Research and Innovation. SYNTHIA is funded through the Innovative Health Initiative.


Last updated on